Xtl Biopharmaceuticals (XTLB) Prepaid Assets (2009 - 2025)

Xtl Biopharmaceuticals (XTLB) has reported Prepaid Assets for 17 consecutive years, with $22000.0 the latest figure, recorded in Q4 2025.

• Quarterly Prepaid Assets fell 99.67% year-over-year to $22000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $22000.0 (down 99.67% YoY) and the FY2025 annual result came in at $22000.0, down 99.67% from the prior year.
• Prepaid Assets slipped to $22000.0 in Q4 2025 per XTLB's latest filing, from $761000.0 in the prior quarter.
• Over the last five years, Prepaid Assets for XTLB reached as high as $7.3 million in Q3 2024 and fell as low as $22000.0 in Q4 2025.
• A 5-year average of $3.0 million and a median of $2.7 million in 2023 frame the typical range for Prepaid Assets.
• Annual changes were most pronounced in 2024 — Prepaid Assets jumped 16467.5% — and 2025, when it slumped 99.67%.
• Year by year, Prepaid Assets stood at $110000.0 in 2021, then fell by 22.73% to $85000.0 in 2022, then plunged by 52.94% to $40000.0 in 2023, then soared by 16467.5% to $6.6 million in 2024, then sank by 99.67% to $22000.0 in 2025.
• According to Business Quant data, Prepaid Assets over the past three periods registered $22000.0, $761000.0, and $6.6 million for Q4 2025, Q2 2025, and Q4 2024 respectively.